Federal court backs FDA’s approval of competitor to Jazz’s sleep drug

The US District Court for Washington, DC, on Wednesday ruled against Jazz Pharmaceuticals’ attempt to undo the FDA’s approval of a competing sleep drug from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Overcoming Provider Adoption Challenges in Healthcare Analytics

Kevin Keenahan, Chief Product Officer, Net Health In recent years, the healthcare industry has seen an explosion in the availability of big data, creating new

August 4, 2023

Tang Capital’s Concentra bids for Singular Genomics days after Deerfield offer

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 19, 2024

Neumora, RayzeBio look to each raise $200M+ in IPOs

Two biotech companies, Neumora and RayzeBio, hashed out their IPO plans Monday morning, detailing hopes to raise around $227 million and $206 million, respectively, in

September 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.